ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic…Read More

You might also be interested in reading Gold hits $3,500 for first time as Trump’s attack on Powell rattles markets.